The acquisition of Univercells Technologies, a provider of novel biomanufacturing technologies, could potentially enhance Donaldson Company's capabilities and market position in the biomanufacturing sector. This could lead to increased revenues and profitability in the future, which could positively impact the company's stock price in the short term.